Taxotere (docetaxel) is a chemotherapy drug approved in the treatment of breast cancer along with other forms of cancer. It is administered intravenously through a vein, and is a member of a family of drugs called taxanes. In 2007, manufacturer Sanofi-Aventis issued a press release touting the efficacy of Taxotere based on a clinical study. However, Sanofi-Aventis failed to inform the FDA, health care providers, and the public that permanent hair loss was observed in a number of the patients taking Taxotere. In December 2015, the FDA announced it had ordered Sanofi-Aventis to change Taxotere’s label to warn patients of the risk of permanent hair loss. While hair loss during chemotherapy is expected, patients undergoing chemotherapy with Taxotere were not warned they could potentially experience permanent hair loss. Permanent hair loss is an extremely debilitating condition, especially for women. We are currently investigating claims for women who suffered permanent hair loss following chemotherapy with Taxotere for breast cancer. Contact: Beau.Darley@beasleyallen.com or Melissa.Prickett@beasleyallen.com.


We're here to help!

We live by our creed of "helping those who need it most" and have helped thousands of clients get the justice they desperately needed and deserved. If you feel you have a case or just have questions please contact us for a free consultation. There is no risk and no fees unless we win for you.

Fields marked    may be required for submission.
  1. I'm an attorney

Number of Taxotere lawsuits growing

The latest report from the U.S. Judicial Panel on Multidistrict Litigation (JPML) shows there are...

Taxotere may add misery of permanent hair loss to...

Some breast cancer survivors have also been left with an enduring, physical reminder of their battle –...

Taxotere MDL trial dates set

Taxotere, a chemotherapy drug approved by the Food and Drug Administration (FDA) to treat breast cancer...

Rare ruling in Taxotere MDL allows claims against...

A recent, rare ruling by the U.S. Judicial Panel on Multidistrict Litigation (JPML) allows claims...

Chemotherapy drug Taxotere lawsuits skyrocketing over...

Many cancer patients who took the chemotherapy drug Taxotere are now experiencing permanent hair loss.

Impressed with the Beasley Allen staff

I am very impressed with the Beasley Allen staff. They were very courteous and patiently explained the aspects of my claim in a way I could understand. If I ever have any need of an attorney in the future I will turn to Beasley Allen.

—Philip